Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 92

    1.

    Recent declines in breast cancer incidence: mounting evidence that reduced use of menopausal hormones is largely responsible.

    Banks E, Canfell K.

    Breast Cancer Res. 2010;12(1):103. Epub 2010 Feb 12.

    PMID:
    20236464
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    Recent epidemiological evidence relevant to the clinical management of the menopause.

    Shapiro S.

    Climacteric. 2007 Oct;10 Suppl 2:2-15. Review.

    PMID:
    17882666
    [PubMed - indexed for MEDLINE]
    3.

    Breast cancer incidence, 1980-2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status.

    Glass AG, Lacey JV Jr, Carreon JD, Hoover RN.

    J Natl Cancer Inst. 2007 Aug 1;99(15):1152-61. Epub 2007 Jul 24.

    PMID:
    17652280
    [PubMed - indexed for MEDLINE]
    Free Article
    4.

    Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population.

    Kerlikowske K, Miglioretti DL, Buist DS, Walker R, Carney PA; National Cancer Institute-Sponsored Breast Cancer Surveillance Consortium.

    J Natl Cancer Inst. 2007 Sep 5;99(17):1335-9. Epub 2007 Aug 14. Erratum in: J Natl Cancer Inst. 2007 Oct 3;99(19):1493.

    PMID:
    17698950
    [PubMed - indexed for MEDLINE]
    Free Article
    5.

    Final Report on Carcinogens Background Document for Formaldehyde.

    National Toxicology Program.

    Rep Carcinog Backgr Doc. 2010 Jan;(10-5981):i-512.

    PMID:
    20737003
    [PubMed - as supplied by publisher]
    6.

    The rise and fall in menopausal hormone therapy and breast cancer incidence.

    Pelucchi C, Levi F, La Vecchia C.

    Breast. 2010 Jun;19(3):198-201. Epub 2010 Feb 21. Review.

    PMID:
    20172726
    [PubMed - indexed for MEDLINE]
    7.

    Hormone therapy and the rise and perhaps fall of US breast cancer incidence rates: critical reflections.

    Krieger N.

    Int J Epidemiol. 2008 Jun;37(3):627-37. Epub 2008 Mar 28.

    PMID:
    18375445
    [PubMed - indexed for MEDLINE]
    Free Article
    8.

    Menopausal hormone therapy.

    Bhavnani BR, Strickler RC.

    J Obstet Gynaecol Can. 2005 Feb;27(2):137-62. Review.

    PMID:
    15937590
    [PubMed - indexed for MEDLINE]
    9.

    The impact of changes in hormone therapy on breast cancer incidence in the US population.

    Coombs NJ, Cronin KA, Taylor RJ, Freedman AN, Boyages J.

    Cancer Causes Control. 2010 Jan;21(1):83-90. Epub 2009 Oct 1.

    PMID:
    19795215
    [PubMed - indexed for MEDLINE]
    10.

    Declines in breast cancer after the WHI: apparent impact of hormone therapy.

    Clarke CA, Glaser SL.

    Cancer Causes Control. 2007 Oct;18(8):847-52. Epub 2007 Jul 6. Review.

    PMID:
    17619153
    [PubMed - indexed for MEDLINE]
    11.

    The incidence of breast cancer and changes in the use of hormone replacement therapy: a review of the evidence.

    Verkooijen HM, Bouchardy C, Vinh-Hung V, Rapiti E, Hartman M.

    Maturitas. 2009 Oct 20;64(2):80-5. Epub 2009 Aug 25. Review.

    PMID:
    19709827
    [PubMed - indexed for MEDLINE]
    12.

    Use of HRT and the subsequent risk of cancer.

    Beral V, Banks E, Reeves G, Appleby P.

    J Epidemiol Biostat. 1999;4(3):191-210; discussion 210-5. Review.

    PMID:
    10695959
    [PubMed - indexed for MEDLINE]
    13.

    Breast cancer and HRT--what are the data?

    Bieber EJ, Barnes RB.

    Int J Fertil Womens Med. 2001 Mar-Apr;46(2):73-8. Review.

    PMID:
    11374658
    [PubMed - indexed for MEDLINE]
    14.

    The impact of menopausal hormone therapy on the incidence of different breast cancer types--data from the Cancer Registry Hamburg 1991-2006.

    Hentschel S, Heinz J, Schmid-Höpfner S, Obi N, Vettorazzi E, Chang-Claude J, Flesch-Janys D.

    Cancer Epidemiol. 2010 Oct;34(5):639-43. Epub 2010 Aug 11.

    PMID:
    20705533
    [PubMed - indexed for MEDLINE]
    15.

    Recent breast cancer trends among Asian/Pacific Islander, Hispanic, and African-American women in the US: changes by tumor subtype.

    Hausauer AK, Keegan TH, Chang ET, Clarke CA.

    Breast Cancer Res. 2007;9(6):R90.

    PMID:
    18162138
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    18.

    Breast cancer incidence in postmenopausal women using testosterone in addition to usual hormone therapy.

    Dimitrakakis C, Jones RA, Liu A, Bondy CA.

    Menopause. 2004 Sep-Oct;11(5):531-5.

    PMID:
    15356405
    [PubMed - indexed for MEDLINE]
    19.

    Trends in hormone therapy and breast cancer incidence - results from the German Network of Cancer Registries.

    Katalinic A, Lemmer A, Zawinell A, Rawal R, Waldmann A.

    Pathobiology. 2009;76(2):90-7. Epub 2009 Apr 9. Review.

    PMID:
    19367129
    [PubMed - indexed for MEDLINE]
    20.

    Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin.

    Anderson GL, Chlebowski RT, Rossouw JE, Rodabough RJ, McTiernan A, Margolis KL, Aggerwal A, David Curb J, Hendrix SL, Allan Hubbell F, Khandekar J, Lane DS, Lasser N, Lopez AM, Potter J, Ritenbaugh C.

    Maturitas. 2006 Sep 20;55(2):103-15. Epub 2006 Jul 11.

    PMID:
    16815651
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk